ASCO® 2024 Insights: "Belzutifan for Advanced Renal Cell Carcinoma"
ASCO® 2024 Insights: "Belzutifan for Advanced Renal Cell Carcinoma"
227 viewsJun 5, 2024
vumedi.com
Hypoxia Inducible Factor-2 (HIF-2) Inhibitor Belzutifan for VHL Treatment | Family Weekend 2024
33:52
Hypoxia Inducible Factor-2 (HIF-2) Inhibitor Belzutifan for VHL Treatment | Family Weekend 2024
510 viewsOct 8, 2024
YouTubeVHL Alliance
Patients with advanced clear-cell renal-cell carcinoma may receive first-line immune checkpoint and antiangiogenic agents, but research is needed to guide subsequent therapy. Findings on belzutifan are summarized in a new Quick Take video. https://nej.md/4cvmO2R | The New England Journal of Medicine
2:29
Patients with advanced clear-cell renal-cell carcinoma may receive first-line immune checkpoint and antiangiogenic agents, but research is needed to guide subsequent therapy. Findings on belzutifan are summarized in a new Quick Take video. https://nej.md/4cvmO2R | The New England Journal of Medicine
1K viewsAug 30, 2024
FacebookThe New England Journal of Medicine
ESMO 2024 Insights: Final Analysis of the Phase 3 LITESPARK-005 Study of Belzutifan vs. Everolimus in Patients With Previously Treated Advanced ccRCC
ESMO 2024 Insights: Final Analysis of the Phase 3 LITESPARK-005 Study of Belzutifan vs. Everolimus in Patients With Previously Treated Advanced ccRCC
115 viewsSep 25, 2024
vumedi.com
Belzutifan Shows Continued Efficacy in Heavily Pretreated Advanced RCC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Belzutifan Shows Continued Efficacy in Heavily Pretreated Advanced RCC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Nov 4, 2022
targetedonc.com
Belzutifan Plus Lenvatinib Versus Cabozantinib for Advanced Renal Cell Carcinoma After Anti–PD-(L)1 Therapy: Open-Label Phase 3 LITESPARK-011 Study | OncLive
11:34
Belzutifan Plus Lenvatinib Versus Cabozantinib for Advanced Renal Cell Carcinoma After Anti–PD-(L)1 Therapy: Open-Label Phase 3 LITESPARK-011 Study | OncLive
1 month ago
onclive.com
Promising real-world outcomes of belzutifan in VHL-associated tumors
2:09
Promising real-world outcomes of belzutifan in VHL-associated tumors
680 viewsAug 1, 2023
YouTubeVJOncology
1:24:35
Patient Education Webinar: Belzutifan
374 views5 months ago
YouTubePheo Para Alliance
0:44
Belzutifan: Managed access treatment for Von Hippel-Lindau (VHL) disease
301 viewsOct 16, 2024
YouTubeNational Institute for Health and Care Excellenc…
3:45
Explanation video: the role of the hypoxia inducible factor (HIF) in the regulation of oxygen
26.1K viewsSep 28, 2021
YouTubenephrology campus
2:55
Belzutifan: A Promising Treatment for Von Hippel-Lindau Disease
1 views5 months ago
YouTubeLatest Stories from People
6:33
One Kidney Cancer's Patient's Journey with Belzutifan: From Clinical Trial to FDA Approval
1.8K viewsJan 16, 2024
YouTubeKidneyCAN
Mechanism of Action - Benzodiazepine Information Coalition
Jul 27, 2022
benzoinfo.com
1:13
Evaluating the evolving role of belzutifan in renal cell carcinoma
163 views10 months ago
YouTubeVJOncology
1:55
Belzutifan real-world vs clinical trial data: comparing efficacy and safety in VHL-associated tumors
591 viewsAug 1, 2023
YouTubeVJOncology
29:08
FDA Approval of Belzutifan | Eric Jonasch, MD
718 viewsNov 29, 2022
YouTubeVHL Alliance
30:51
Belzutifan Trial: Phase 2 study to evaluate the efficacy and safety (Dr. Hendifar) - June 15, 2022
1K viewsJun 22, 2022
YouTubeNeuroendocrine Cancer Foundation
3:26
Highlights on belzutifan in previously treated advanced clear cell RCC: The LITESPARK-005 study
1.9K viewsOct 21, 2023
YouTubeEuropean Society for Medical Oncology (ESMO)
5:01
FDA D.I.S.C.O. Burst Edition: FDA approval of Welireg (belzutifan) for adult patients with von Hi...
340 viewsApr 2, 2024
YouTubeU.S. Food and Drug Administration
ASCO® GU 2025 Insights: Efficacy Outcomes With Belzutifan vs. Everolimus by Baseline Disease Characteristics and Burden Subgroups - LITESPARK-005 Study
Mar 4, 2025
vumedi.com
2:36
Kidney cancer research: Belzutifan versus everolimus | Dana-Farber Cancer Institute
392 viewsAug 22, 2024
YouTubeDana-Farber Cancer Institute
2:03
Welireg, a new drug to fight cancer, could offer hope for many
Oct 6, 2021
firstcoastnews.com
2:53
MECHANISM OF HORMONE ACTION
345.3K viewsSep 16, 2014
YouTube7activestudio
15:48
Hypoxia Inducible Factor (HIF) Part 1
43.3K viewsJan 12, 2015
YouTubeElliot Nicholson
33:29
Welireg (Belzutifan) Q&A Session with Dr. Othon Iliopoulos
1.4K viewsOct 26, 2021
YouTubeVHL Alliance
6:23
HIF-2a inhibition in Advanced Renal cell Carcinoma
744 views1 month ago
YouTubeOncUpdates: Latest Oncology Insights
2:23
Belzutifan improves PFS, ORR in clear cell renal cell carcinoma
199 viewsFeb 20, 2024
YouTubeecancer
13:50
Antibiotics Classification According to Mechanism of Action | Antibiotics | Antibiotics Classes
142.3K viewsApr 6, 2020
YouTubeSolution- Pharmacy
2:48
Belzutifan plus palbociclib shows modest activity With Manageable Safety in Heavily Pretreated Kidney Cancer
1 month ago
Vimeoecancer
1:57
LITESPARK-029: belzutifan with fulvestrant in ER+/HER2- breast cancer
126 viewsDec 16, 2024
YouTubeVJOncology
See more